These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37481435)

  • 61. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption.
    Kerstens MN; Kobold AC; Volmer M; Koerts J; Sluiter WJ; Dullaart RP
    Clin Chem; 2011 Nov; 57(11):1607-11. PubMed ID: 21865483
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial.
    See EJ; Chaba A; Spano S; Maeda A; Clapham C; Liu J; Khasin M; Liskaser G; Eastwood G; Bellomo R
    J Crit Care; 2024 Feb; 79():154453. PubMed ID: 37890357
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
    Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
    Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
    Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
    Spannella F; Giulietti F; Balietti P; Borioni E; Lombardi FE; Ricci M; Cocci G; Landi L; Sarzani R
    J Hypertens; 2017 Nov; 35(11):2315-2322. PubMed ID: 28614094
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
    Sturrock ND; Lang CC; Coutie WJ; Struthers AD
    J Hypertens; 1995 Sep; 13(9):987-91. PubMed ID: 8586834
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis.
    Corrêa TD; Jeger V; Pereira AJ; Takala J; Djafarzadeh S; Jakob SM
    Crit Care Med; 2014 Aug; 42(8):e550-9. PubMed ID: 24797374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
    Williams GH; Hollenberg NK; Brown C; Mersey JH
    J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Cefis M; Cerri B; Pollavini G; Muiesan G
    Eur Heart J; 1992 Jan; 13(1):15-21. PubMed ID: 1577025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study.
    Sezai A; Soma M; Hata M; Yoshitake I; Unosawa S; Wakui S; Shiono M
    Ann Thorac Cardiovasc Surg; 2011; 17(5):487-93. PubMed ID: 21881353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of the Addition of Angiotensin II in Patients With Shock After Cardiac Surgery at a Veterans Affairs Medical Center.
    Bird S; Chand M; Tran TL; Ali S; Awad SS; Cornwell LD; Schutz A; Jimenez E
    Ann Pharmacother; 2023 Feb; 57(2):141-147. PubMed ID: 35658717
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blood pressure and the renin--angiotensin--aldosterone system.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():261s-263s. PubMed ID: 7032815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.